Huge January News And An Anticipated Nasdaq Listing Are Just 2 Reasons To Pay Attention To This New Biotech Idea
The Complete Report Arrives 7:00PM EST Wednesday
*SMS Sign-up Details Below*
Humanity is in a very dark place right now.
In recent years we've been dealing with all types of anxiety-inducing issues, from war to famines to diseases and climate change.
But it feels like the pace was picked up in the pandemic.
Separation has come in all forms from our neighbors, our family, our churches, our schools, our friends, etc.
It has led to an increase in Anxiety, Stress, Addiction, Depression, and Suicides. (Source 1)
In the U.S., the CDC has reported that more than 50% of people will be diagnosed with a mental illness or disorder at some point in their lifetime. (Source 2)
Most people just don’t have the resources available or are unresponsive to current treatments on the market.
What the street’s been searching for is a company that has the types of material advantages that will make it a winner in the mental health industry.
I've discovered a company that has a world-class management and research team behind it, and an undeniably incredible market advantage at the research and API level.
At 7:00PM EST today, you'll receive the complete report.
To give you an idea of what's to come, I've put together a few potential catalysts that could spark this profile to a possible breakout.
3 Potential Breakout Catalysts - Key Details To Know Now
#1. The company just announced that it has made a major analysis breakthrough that should be a true game-changer for the company near term.
#2. Furthermore, the company recently signed an LOI to develop a new platform. With the new platform, the hope is to create new treatments that other companies aren't capable of.
#3. According to the company's website, they are anticipating a Nasdaq listing early in 2022. If/when this occurs, it could draw serious attention to a company that is currently flying below Wall Street's radar.
When you have a moment, do this: